MA39449A1 - Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci - Google Patents
Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ciInfo
- Publication number
- MA39449A1 MA39449A1 MA39449A MA39449A MA39449A1 MA 39449 A1 MA39449 A1 MA 39449A1 MA 39449 A MA39449 A MA 39449A MA 39449 A MA39449 A MA 39449A MA 39449 A1 MA39449 A1 MA 39449A1
- Authority
- MA
- Morocco
- Prior art keywords
- optically active
- salts
- obtaining enantiomers
- pirlindole
- active pirlindole
- Prior art date
Links
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 title abstract 2
- IWVRVEIKCBFZNF-UHFFFAOYSA-N LSM-1636 Chemical compound C1CNC2CCCC3=C2N1C1=CC=C(C)C=C13 IWVRVEIKCBFZNF-UHFFFAOYSA-N 0.000 title abstract 2
- 229950002220 pirlindole Drugs 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La présente invention concerne un nouveau procédé d'obtention d'énantiomères de pirlindole optiquement actifs, sous forme d'une base libre ou sous forme de sels pharmaceutiquement acceptables. Les produits obtenus selon la présente invention sont énantiomériquement purs et sont utiles en médecine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/PT2014/000027 WO2015171003A1 (fr) | 2014-05-09 | 2014-05-09 | Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
MA39449A1 true MA39449A1 (fr) | 2017-11-30 |
Family
ID=50819929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA39449A MA39449A1 (fr) | 2014-05-09 | 2014-05-09 | Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci |
Country Status (30)
Country | Link |
---|---|
US (1) | US9682986B2 (fr) |
EP (1) | EP3140265B1 (fr) |
JP (1) | JP6516769B2 (fr) |
KR (1) | KR102258709B1 (fr) |
CN (1) | CN106414376B (fr) |
AU (1) | AU2014393488C1 (fr) |
BR (1) | BR112016025918B1 (fr) |
CA (1) | CA2948604C (fr) |
CY (1) | CY1122367T1 (fr) |
DK (1) | DK3140265T3 (fr) |
EC (1) | ECSP16086217A (fr) |
ES (1) | ES2753403T3 (fr) |
HR (1) | HRP20192029T1 (fr) |
HU (1) | HUE046437T2 (fr) |
IL (1) | IL248853B (fr) |
LT (1) | LT3140265T (fr) |
MA (1) | MA39449A1 (fr) |
MX (1) | MX357918B (fr) |
NZ (1) | NZ726129A (fr) |
PH (1) | PH12016502234B1 (fr) |
PL (1) | PL3140265T3 (fr) |
PT (1) | PT3140265T (fr) |
RS (1) | RS59499B1 (fr) |
RU (1) | RU2666731C2 (fr) |
SA (1) | SA516380265B1 (fr) |
SI (1) | SI3140265T1 (fr) |
TN (1) | TN2016000496A1 (fr) |
UA (1) | UA118696C2 (fr) |
WO (1) | WO2015171003A1 (fr) |
ZA (1) | ZA201607722B (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2948604C (fr) | 2014-05-09 | 2021-06-15 | Tecnimede Sociedade Tecnico-Medicinal S.A. | Procede d'obtention d'enantiomeres de pirlindole optiquement actifs et de sels de ceux-ci |
CN106413713B (zh) * | 2014-05-09 | 2020-07-14 | 特克尼梅德医疗技术股份公司 | 用作药物的吡吲哚对映异构体的药学上可接受的盐 |
EP3392250A1 (fr) | 2017-04-21 | 2018-10-24 | Tecnimede-Sociedade Tecnico-Medicinal, S.A. | Procedé pour la préparation de l'anneau de pipérazine pour la synthèse de pyrazinocarbazole |
EP3392251A1 (fr) | 2017-04-21 | 2018-10-24 | Tecnimede-Sociedade Tecnico-Medicinal, S.A. | Procedé pour la préparation des enantiomères de pirlindole et leurs sels |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2281085C2 (ru) * | 2004-05-25 | 2006-08-10 | Закрытое акционерное общество "Мастерлек" | Антидепрессивные лекарственные средства для парентерального применения на основе сульфонатных солей пирлиндола |
CA2948604C (fr) | 2014-05-09 | 2021-06-15 | Tecnimede Sociedade Tecnico-Medicinal S.A. | Procede d'obtention d'enantiomeres de pirlindole optiquement actifs et de sels de ceux-ci |
-
2014
- 2014-05-09 CA CA2948604A patent/CA2948604C/fr active Active
- 2014-05-09 UA UAA201611334A patent/UA118696C2/uk unknown
- 2014-05-09 PL PL14726442T patent/PL3140265T3/pl unknown
- 2014-05-09 ES ES14726442T patent/ES2753403T3/es active Active
- 2014-05-09 CN CN201480078731.6A patent/CN106414376B/zh active Active
- 2014-05-09 MX MX2016014703A patent/MX357918B/es active IP Right Grant
- 2014-05-09 RS RS20191433A patent/RS59499B1/sr unknown
- 2014-05-09 BR BR112016025918-1A patent/BR112016025918B1/pt active IP Right Grant
- 2014-05-09 AU AU2014393488A patent/AU2014393488C1/en active Active
- 2014-05-09 WO PCT/PT2014/000027 patent/WO2015171003A1/fr active Application Filing
- 2014-05-09 EP EP14726442.8A patent/EP3140265B1/fr active Active
- 2014-05-09 LT LT14726442T patent/LT3140265T/lt unknown
- 2014-05-09 NZ NZ726129A patent/NZ726129A/en unknown
- 2014-05-09 DK DK14726442T patent/DK3140265T3/da active
- 2014-05-09 US US15/309,906 patent/US9682986B2/en active Active
- 2014-05-09 MA MA39449A patent/MA39449A1/fr unknown
- 2014-05-09 HU HUE14726442A patent/HUE046437T2/hu unknown
- 2014-05-09 TN TN2016000496A patent/TN2016000496A1/en unknown
- 2014-05-09 KR KR1020167031371A patent/KR102258709B1/ko active IP Right Grant
- 2014-05-09 PT PT147264428T patent/PT3140265T/pt unknown
- 2014-05-09 SI SI201431386T patent/SI3140265T1/sl unknown
- 2014-05-09 JP JP2016567540A patent/JP6516769B2/ja active Active
- 2014-05-09 RU RU2016148181A patent/RU2666731C2/ru active
-
2016
- 2016-11-09 ZA ZA2016/07722A patent/ZA201607722B/en unknown
- 2016-11-09 IL IL248853A patent/IL248853B/en active IP Right Grant
- 2016-11-09 EC ECIEPI201686217A patent/ECSP16086217A/es unknown
- 2016-11-09 SA SA516380265A patent/SA516380265B1/ar unknown
- 2016-11-09 PH PH12016502234A patent/PH12016502234B1/en unknown
-
2019
- 2019-11-08 HR HRP20192029TT patent/HRP20192029T1/hr unknown
- 2019-11-13 CY CY20191101194T patent/CY1122367T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020500066A1 (en) | Carboxamides as modulators of sodium channels | |
CY1121062T1 (el) | Φαρμακευτικες συνθεσεις για την αντιμετωπιση της νοσου alzheimer | |
CR20130629A (es) | Compuestos de 2-(2,4,5-anilino sustituido)pirimidina | |
MX2016010056A (es) | 6-heteroariloxi o 6-ariloxi-quinolina-2-carboxamidas y metodos de uso. | |
MY192354A (en) | 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors | |
MX2019000536A (es) | Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1. | |
WO2014145205A3 (fr) | Procédés et compositions de modulateurs de la transcription de p27kip1 | |
MX2016011105A (es) | Inhibidores de monoacilglicerol aciltransferasa 2 (mgat2) de dihidropiridinona para usarse en el tratamiento de trastornos metabolicos. | |
MX2018004664A (es) | Antagonistas de ep4. | |
MA39449A1 (fr) | Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci | |
JOP20190233A1 (ar) | نظائر بنزوازيبين بوصفها عوامل مثبطة لتيروزين كيناز بروتون | |
MX2015001917A (es) | Composiciones farmaceuticas de memantina. | |
DOP2018000103A (es) | Forma cristalina de 2-(2,6-diclorofenil)-1-[(1s,3r)-3-(hidroximetil)-5-(3-hidroxi-3-metilbutil)-1-metil-3,4-dihidroisoquinolin-2(1h)-il]etanona para tratar enfermedad de parkinson. | |
EA201790315A1 (ru) | Модуляторы x-рецепторов печени | |
PH12015502676A1 (en) | 4-(5-(4-chlorophenyl)-2-(2-cyclopropylacetyl)-1,4-dimethyl-1h-pyrrol-3-yl)benzenesulfonamide as alpha 7 nachr modulator | |
PH12016502235A1 (en) | Pharmaceutically acceptable salts of pirlindole enantiomers for use in medicine | |
TN2017000448A1 (en) | Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer's disease | |
PH12016502527B1 (en) | Stabilized desmopressin | |
PH12020500385A1 (en) | A process for preparation of triaminopyrimidine compound and intermediates thereof | |
FR3028760B1 (fr) | Composition cosmetique de soin et/ou de maquillage de la peau | |
PH12019502792A1 (en) | Tetrahydropyridopyrazine modulators of gpr6 | |
BR112017003430A2 (pt) | comprimido revestido com filme para o tratamento de dor aguda |